Alan Waxman and TSSP Sub‑Fund HoldCo report stakes in CARIS Life Sciences (NASDAQ: CAI)
Rhea-AI Filing Summary
CARIS LIFE SCIENCES, INC. Schedule 13G/A (Amendment No. 2) discloses joint reporting by TSSP Sub-Fund HoldCo, LLC and Alan Waxman regarding beneficial ownership of Common Stock. As of March 31, 2026, the filing bases percentages on 282,579,919 shares outstanding as of February 26, 2026.
The cover data show Sub-Fund HoldCo with 13,666,128 shares (listed shared voting and dispositive power) representing 4.8% and Alan Waxman with 14,385,399 shares (listed shared voting and dispositive power) representing 5.1%. The filing describes layers of entity ownership and management relationships and includes joint filing and authorization exhibits.
Positive
- None.
Negative
- None.
Insights
Joint disclosure clarifies ownership and control lines across related entities.
The filing attributes shared voting and dispositive power to reported entities, listing specific share counts and a February 26, 2026 outstanding-share base of 282,579,919. It traces ownership through multiple LLCs and identifies management links between Sub-Fund HoldCo and Mr. Waxman.
Key dependencies include the holding structures named (Barnett Equity Holdings entities, TOP III Barnett Investments, Sixth Street affiliates) and the joint filing agreement. Subsequent filings could update percentages if holdings or the outstanding share count change.
Disclosure uses a standard disclaimer of beneficial ownership and attaches authorization exhibits.
The report expressly disclaims beneficial ownership of securities held directly by several named entities and attaches an Agreement of Joint Filing and an Authorization and Designation Letter. It ties percentage calculations to the issuer's Form 10-K share count disclosed on February 26, 2026.
Material filing qualifiers include the formal disclaimers and the joint-filing mechanism; cash-flow treatment and transaction intent are not part of this disclosure.
Key Figures
Key Terms
Agreement of Joint Filing regulatory
beneficial ownership regulatory
Authorization and Designation Letter regulatory
AI-generated analysis. How Rhea-AI works. Not financial advice.